Abdulrhman Althagafi
Summary
Experienced Clinical Researcher with a proven track record of publishing and presenting impactful research papers that demonstrate a deep understanding of clinical practices and the pharmaceutical field. PharmD degree holder with a strong background in clinical pharmacy, medical affairs, and scientific communication. Skilled in interpreting and presenting complex clinical data. Passionate advocate for evidence-based medicine and innovation in healthcare.
Overview
6
6
years of professional experience
Work History
Manager, Model of Care (MOC)
Makkah Health Cluster
10.2024 - Current
- Facilitating Model of Care (MOC) change initiatives in healthcare and analyzing MOC proposals for patient safety, regulatory compliance, and workflow impact
- Collaborated with cross-functional teams, including clinical operations and quality functions, to deliver ecosystem-wide solutions using agile ways of working
Hospital Pharmacist
Makkah Health Cluster
10.2020 - 01.2024
- Provided local medical/scientific therapy area expertise as a drug information pharmacist, supporting clinical decisions to facilitate faster access to safe medications
Immune oncology product specialist
Bristol-Myers Squibb
08.2019 - 10.2020
- Delivered therapy area expertise in immune oncology (lung cancer, melanoma, renal cell carcinoma), collaborating with medical affairs and marketing teams to support strategic plans
- Collaborated with cross-functional teams (marketing, medical, clinical research) to align on strategic objectives
Education
Doctor of Pharmacy (PharmD) -
College of Pharmacy, Umm Al-Qura University (UQU)
01.2019
Skills
- Clinical Research Expertise
- Project management
- Product Launch Expertise
- Proficient Written Communication
Publications
- Views and Perceptions of Medical Representatives and Physicians about the Role of Medical Representatives and Pharmaceutical Advertisement in Saudi Arabia - A Pilot Study, Journal of Research in Pharmacy Practice, 2022
- Prescribing Patterns of Antidiabetics in Type 2 Diabetes and Factors Affecting Them - A Cross-Sectional Survey, Saudi Pharmaceutical Journal, 2022
- Are Fluoroquinolones Safe for Diabetic Patients? A Systematic Review of Dysglycemia and Neuropathy Adverse Effects of Fluoroquinolones, Therapeutic and Risk Management Journal, 2021
- Medication-related Problems in Diabetic Patients During Ramadan, International Journal of Environmental Research and Public Health, 2019
Timeline
Manager, Model of Care (MOC)
Makkah Health Cluster
10.2024 - Current
Hospital Pharmacist
Makkah Health Cluster
10.2020 - 01.2024
Immune oncology product specialist
Bristol-Myers Squibb
08.2019 - 10.2020
Doctor of Pharmacy (PharmD) -
College of Pharmacy, Umm Al-Qura University (UQU)
Similar Profiles
Saja Sultan ALHAZMISaja Sultan ALHAZMI
Director of School Health Administration at Makkah Health ClusterDirector of School Health Administration at Makkah Health Cluster
DUJA ALJUAIDDUJA ALJUAID
Sleep and Family Medicine Consultant at Makkah Health Cluster, MOHSleep and Family Medicine Consultant at Makkah Health Cluster, MOH
MUHAMMAD PERVEZ AKHTARMUHAMMAD PERVEZ AKHTAR
Resident Physician, Internal Medicine/Nephrology at Health Cluster Mecca,ministry of Health KSAResident Physician, Internal Medicine/Nephrology at Health Cluster Mecca,ministry of Health KSA